Abstract
Reduced graphene oxide -iron oxide quantum dots (QDs) with intrinsic photoluminescent and superparamagnetic properties were synthesized through a green, hydrothermal method that simultaneously reduced and shattered graphene nanosheets to form the dots. The structure, morphology, properties and cell viability of these QDs were investigated. The QDs emitted violet light when excited at 320 nm, possessed no residual magnetization upon magnetic hysteresis tests, and had low cytotoxicity to healthy cells at low concentrations. The suitability of the QDs for fluorescent and magnetic resonance dual-modality imaging was shown by in vitro imaging with dermal fibroblast cells and T2 relaxation time. A drug could be loaded onto the surface of the QDs, with a loading ratio of drug to QD of 0.31:1. The drug achieved a steady but full release from the QDs over 8 h: these drug-loaded QDs could be manipulated by an external magnetic stimulation for targeted drug delivery. The potential for use as a cancer photothermal therapy was demonstrated by both a rapid, ~50 shown to improve when an ionic drug was coated on the surface.
Introduction
Biomedical technology is undergoing a period of rapid development, and one of the keys to this advancement is nanotechnology [1] . Graphene, and its chemically oxidized derivative graphene oxide (GO), have been investigated for drug delivery, biosensing, and cancer photothermal therapy as they have a large surface area, ample functional groups on the surface, photothermal properties and/or low cytotoxicity [2, 3] . Iron oxide (IO) nanoparticles have also been studied for biomedical purposes [4] . Their superparamagnetic (i.e. they hold no residual magnetic force and can be manipulated by external magnetic fields) behavior allows for them to be used for targeted therapeutic delivery [5] . They can be imaged in vivo
by Magnetic Resonance Imaging (M.R.I.), enabling the visualisation of tumors and the circulatory system, as well as finding use in magnetic hyperthermia [6, 7] .
IO can be deposited onto GO to form GO-IO or reduced graphene oxide (rGO)-IO hybrids [8] [9] [10] [11] (the chemical deposition may reduce GO to rGO during the synthesis [12] ), which can combine the interesting aspects of both individual nanoparticles [8] [9] [10] [11] [12] . Previous work [9, 12] has shown that graphene-IO nanoparticles can be used for targeted drug delivery, M.R.I., and photothermal therapy; the functional groups of GO or rGO allow for drug loading while the superparamagnetic properties of IO enable the hybrids to be used for targeted drug delivery using an external magnetic stimulus and M.R.I.. Both graphene [13] and IO [14] were shown to absorb near infrared (NIR) light, which was converted into heat for photothermal therapy. For instance, GO-IO reduced the cancer cell viability by ~90% by using a 2 W cm -2 laser for 5 min [9] , and rGO-IO achieved the full ablation of tumours within mice within 24 h using a 0.5 W cm -2 laser as the irradiation source [12] . However, no intrinsic photoluminescent properties were demonstrated for the graphene -IO nanoparticles reported in the literature [11, 15, 16] . The fluorescent imaging capability of the rGO-IO nanoparticles were from dyes (polyfluorene [11] and cyanine [12] ) bonded to the nanoparticle surface. The photoluminescent properties of the GO-IO were attributed to the bonded doxorubicin, which the GO-IO quenched in comparison to free doxorubicin [9] ; these nanoparticles were approximately 50 -300 nm in size and did not possess intrinsic photoluminescent properties.
Quantum dots (QDs) emit a luminescence due to quantum confinement effects [17] .
Conventionally, QDs were made of compounds like cadmium selenide (CdSe) or cadmium telluride (CdTe), but they were found to be cytotoxic during in vitro cell tests due to the photolysis release of cadmium ions and the uncoiling of DNA helical strands [18, 19] . This led to the development of biocompatible carbon-based QDs, with QDs derived from carbohydrates [20] , nanodiamonds [21] , and graphene [22] [23] [24] [25] . Graphene QDs (GQDs) can be created by ultrasonication [22] , chemical reduction [23] , photo-reduction [24] , and hydrothermal cutting [25] . These carbon QDs emit the same level of luminescence as the cadmium QDs, but do not carry the same cytotoxic risk. It has been shown that GQDs could enter cells but did not enter the nucleus of stem cells during in vitro tests; they maintained a high (80%) viability for neurosphere and pancreas progenitor cells up to 100 µg ml -1 after 72
h [26] , and carboxylated GQDs caused no acute toxicity to rats after 22 days post injection at a concentration of 10 mg kg -1 [27] . Carbon QDs can be excreted rapidly from the body after being administered through intravenous, intramuscular or subcutaneous injections [28] .
To the authors' knowledge, biocompatible graphene-based magnetic QDs that are intrinsically both superparamagnetic and photoluminescent have not yet been reported.
Quantum dots with magnetic properties (MQDs) can by synthesized by either doping conventional QDs (for example CdSe, or CdTe ) with metal elements like manganese [29] , nickel [30] , or gadolinium [31] , or by encasing conventional QDs with IO [32] in silica spheres. These MQDs possess the photoluminescent properties of conventional QDs and the magnetic properties of the doping agent or the encapsulated IO, but they contain cytotoxic compounds such as cadmium selenium or cadmium telluride and are therefore cytotoxic without a biocompatible passivation coating [30] . The aim of this work was to synthesize magnetic graphene-IO quantum dots (herein MGQDs) as a multifunctional nanosystem for fluorescent imaging, M.R.I., targeted drug delivery and photothermal therapy for concurrent detection, monitoring and treatment of diseases. The MGQDs were synthesized by depositing IO on GO surface, followed by autoclaving to reduce GO into rGO and form the MGQDs.
Their structure, morphology, cell viability, drug release behavior, fluorescent imaging and M.R.I. capabilities and photothermal properties were assessed.
Experimental

Materials
The following chemicals were used as purchased from Sigma Aldrich; sulfuric acid ( were acquired from Fisher Scientific UK.
Preparation of graphene oxide -iron oxide nanoparticles
Graphene oxide was synthesized from a modified Hummers method [33] and GO-IO was prepared according to methods described in the literature with some modifications [8, 34] .
The freeze-dried GO powder (1 g) was dispersed in 150 ml of distilled water through stirring and sonication for 1 h and the pH of the suspension was raised to pH = 8 with the addition of ammonium hydroxide NH 4 OH. Separately, ferrous chloride tetrahydrate FeCl 2 -4H 2 O (5.4 g) and ferric chloride hexahydrate FeCl 3 -6H 2 O (4 g) were dissolved in 135 ml distilled water.
The GO suspension and the solution of IO precursors were added together, ammonium hydroxide was added drop wise until a pH = 10 was reached, and then the mixture was stirred for 2 h under a nitrogen atmosphere at ambient temperature. The precipitate, iron oxide coated graphene oxide (GO-IO), was washed with distilled water, ethanol and dichloromethane to remove residual chemicals, separated from unbound, hydrophobic IO precipitate by decanting the GO-IO as the supernatant from an aqueous suspension, before being re-dispersed in distilled water (~ 3 mg ml -1 ) by sonication for 1 h in a Fisherbrand sonication bath (230 V, 50-60 Hz). As a control sample, IO was prepared using the same method but without the addition of GO.
Preparation of reduced graphene oxide-iron oxide quantum dots
The aqueous GO-IO suspension (~ 3 mg ml -1 ) was treated in a Parr Series 4000 autoclave at 
Drug loading onto quantum dots
Lidocaine hydrochloride (LH) (0.1 mg ml -1 ) was added to a 100 ml suspension of MGQDs (0.1 mg ml -1 ) under stirring for 48 h. The suspension was centrifuged at 9000 rpm for 1 hour, after which the supernatant (containing unbound LH) was removed and the precipitate was re-dispersed in water. This process was repeated several times to remove all of the unbound LH. The MGQD-LH was then freeze-dried and stored in a desiccator.
Characterization
Transmission electron microscopy (TEM), energy dispersive X-ray spectroscopy (EDS), and 
where "ɸ" is the fluorescence quantum yield, "Grad" is the gradient of the curve of emission versus absorbance, "η" is the refractive index for the solvent used in the solution, and "qd" 
Cell viability and imaging
Human Dermal fibroblast cells were isolated and cultured, as described previously [36] , in DMEM at 37 o C and 5% CO 2 environment. When the culture was 50% confluent, the cells were collected by treating with a trypsin solution for 10 min and centrifuging the cell suspension to form a pellet at 1000 rpm for 5 min using a Hettich Rotafix 32A centrifuge. An Olympus CK40 microscope and a Leica TCS SP8 two-photon confocal microscope (excitation source 690 nm, emission filter 360 nm) were used for cell imaging.
For the two-photon fluorescent imaging, the cells were incubated with either 50 µg ml -1 or 100 µg ml -1 MGQDs for 12 h before the cells were fixed with glutaraldehyde. 
Drug release from MGQDs
Photothermal measurements
The temperature of aqueous suspensions of MGQDs and GQDs (1.5 ml, concentration of 50 µg ml -1 and 100 µg ml -1 ) under irradiation from a near-infrared continuous laser (wavelength: 808 nm; laser power: 2, 5, 7.5 W cm -2 ) was measured as a function of time. Distilled water was studied as a control.
Photothermal experiments on HeLa cells incubated with suspensions of MGQDs and
GQDs were carried out with a near-infrared continuous laser (wavelength: 808 nm; laser power: 2.5 W cm -2 ). HeLa cells were seeded to a density of 5000 cells per well of a 96 well culture plate (BD Falcon, U.S.). Cells were incubated at 37 o C in a 5% CO 2 atmosphere for 24 h to allow for reattachment. After incubation, the cell culture medium was replaced by the MGQD or GQD suspension (100 µl of cell medium with a 50 µg ml -1 suspension of MGQD or GQD). After 4 h incubation with the QDs, the cells were irradiated by a laser for 20 min or 30 min. After incubation overnight, the QD suspension medium was removed and the cells were washed twice with PBS. To test the viability of the cells after irradiation, 100 µl of CCK-8 solution was added to each well and the cells were incubated for 2 h. The optical density of the cell solution was read on a microplate reader (Varioskan Flash, Thermo Scientific), with measurements taken at 450 nm.
Biostability
MGQD and MGQD-LH were dispersed in distilled water, PBS and FCS at a concentration of 50 µg ml -1 . Suspensions were imaged using a digital camera after predetermined intervals.
Statistical analysis
Statistical analysis (p < 0.05) and graphing were completed through MatLab 2012a software.
Size analysis of TEM images was conducted through ImageJ software, with 60 separate samples taken over several images.
Results and discussion
Structure
MGQDs were synthesized by coating the surface of GO with IO using the precursors of IO, followed by a hydrothermal treatment to simultaneously reduce GO into rGO and shatter the nanosheets to form MGQDs. The synthesis procedure is illustrated in Figure 1 . in the polydisperse MGQD water suspension [37] . The diameter of the MGQDs is larger than hydrothermally reduced GQDs (5-25 nm) previously reported by by other groups [25, 38, 39] , but these papers use either a longer hydrothermal treatment time (24 h) [38, 39] or an additional oxidation procedure to further reduce the size of their GO before the hydrothermal treatment [25] . The diameter is, however, similar to that of the GQDs (51.9 nm) prepared by the same oxidation and hydrothermal treatment method in our group [40] . The MGQDs are identifiable in both the conventional and high resolution TEM images in dark contrast ( Figure 2A1 -2A2, 3A) on the amorphous carbon film support due to the presence of high density IO (4.9 -5.2 g cm -3 for magnetite [41] ) within the MGQDs as well as mass-thickness contrast, similar to the identification of IO on GO-IO reported in the literature [9] . Under HR-TEM, a region of magnetite (Fe 3 O 4 ) within an MGQD ( Figure 3B) can be identified by the (400) lattice spacing ~0.227 nm [42] , with a similar region of magnetite in Figure 3C , 3D and 3E identifiable by the (220) lattice spacing of ~0.345 nm [42, 43] . A region of folded graphene (or rGO) layers can also be seen in Figure 3D and 3E by the (002) lattice spacing of ~0.347 nm and the wrinkled structure similar to the literature [44, 45] . The region of graphene in Figure 3D and 3E contrasts in structure to the amorphous carbon support on the TEM grid, shown in Figure S1 of Supplemental Information and also present in the upper section of Figure 3C . The region of IO in Figure 3D and 3E appears to be on the surface of the graphene region. Figure 3F shows a layer-structured nanoparticle with a darker layer on top of a lighter layer, which may be interpreted as a layer of dense IO coated on top of a graphene surface. The inset of Figure 3G shows our proposed structure of MGQD, with IO coated on top of the folded graphene sheets and with some edges of graphene sheets uncovered due to the fracture of IO-graphene during the hydrothermal reduction. As the residual IO precursors and IO were removed from GO-IO nanoparticles before hydrothermal treatment, we expect the amount of individual A-IO particles present in the MGQDs to be minimal, if any.
As described previously, the average thickness of the MGQDs from AFM is 2.3 nm, which is thicker than the reported thickness of graphene (0.37 nm [46] ), rGO (~0.8 nm [47]) or the GQDs prepared using the same hydrothermal reduction method (1.5 nm [40] ). This suggests that the IO coating on both sides of the MGQD surface is likely 0.8 -1.9 nm thick; however, we do not exclude the possibility of the presence of some residual thicker nanoparticles in the MGQD. IO growth on GO was reported to be smaller than pristine IO growth due to the dispersed nucleation of Fe 3+ by the oxygen functional groups (C=O) of GO [48] , and a similar effect may have occurred during the synthesis of the IO on the GO-IO followed by reduction of GO into rGO during hydrothermal cutting. The composition of the MGQD in Figure 2A -2 can be seen in the EDS spectrum in Figure 2C , which confirms the presence of iron (0.72, 6.42, and 7.08 keV) [49, 50] . The oxygen (0.54 keV) was from the IO and the residual oxygenated groups in the hydrothermally reduced GO while carbon (0.3 keV) was from the rGO and carbon-coated , all from hematite [53] .
A further analysis of the structure of the MGQDs and the structural change during autoclaving was performed through Raman spectroscopy of GO, IO, GO-IO, GQDs, A-IO and MGQDs ( Figure 4B ). GO can be identified by the G band at 1591 cm -1 (E 2g mode) and the D band at 1322 cm -1 (A 1g ) [63] . The IO is a mixture of magnetite and maghemite, with the maghemite caused by the local extreme heating of the IO powder by the laser source as it was not identified in the XRD analysis [64, 65] . The peak at 300 cm -1 and the broad peak at 660 MGQD is in the form of a film on the surface of the MGQD as previously described, and only has one outer surface exposed to the effects of the hydrothermal treatment, unlike the A-IO particles which have all the surfaces exposed. This reduces the effect of the hydrothermal reaction on the IO on graphene surface, leading to a different chemical composition.
FT-IR spectra of the nanomaterials are shown in Figure 4C . GO has C-O bonds at 1043 cm -1 , C=C bonds at 1621 cm -1 and C=O bonds at 1720 cm -1 . On the IO spectrum, a peak for the Fe-O bond is present at 551 cm -1 [8] . For the GO-IO, the synthesis procedure of IO on the GO has led to the shift of the C=C aromatic bonds of the GO from 1621 cm -1 to 1593 cm and IO [66] . Figure 4D shows the TGA curves of the MGQD and its control samples in a nitrogen
atmosphere. TGA suggests that GO is oxidized graphene (dissociation of epoxide and hydroxyl groups at ~200 o C is 23% of the total dry mass). IO has limited dissociation of ~5%
(similar to magnetite) as it does not possess any functional groups on the surface to be dissociated [70] . GO-IO is a mixture of GO and IO with a main mass loss (~27% of the dry 
Photoluminescent and magnetic properties
The photo-physical properties of the nanoparticles were characterized using steady-state UVVis spectroscopy. As shown in Figure 5A , MGQDs and GQDs have absorbance peaks at 270 nm and 320 nm, with the MGQDs also exhibiting the characteristic absorbance trait of A-IO in the wavelength region 400 to 500 nm. The emission characteristics of the MGQDs are presented in Figure 5B . Here, excitation of the MGQDs at 320 nm (corresponding to the peak in the excitation spectrum) yields an emission spectrum with a peak at 398 nm. This emission value is slightly lower than that (420 nm) observed for the GQDs prepared by the same hydrothermal method [40] . Quantum yield measurements (using Equation 1) gave a value of 7.9% for the MGQDs, similar to the published literature for GQDs (5.5-14%) prepared by other groups [20, 23, 24, 75] and slightly lower than the GQDs prepared using the same method (9.4%) [40] . These suggest the presence of IO slightly quenches the luminescence of GQDs.
The photos in the inset confirm the photoluminescence (PL) properties of the MGQDs (right), in contrast to the control sample of PBS solution. MGQDs, in a 1 mg ml -1 aqueous suspension, have a PL lifetime of 1.9 ns ( Figure 5C ), similar to GQDs and conventional QDs in the literature (range of 1-10 ns) [76] [77] [78] [79] , and slightly lower than the GQDs prepared using the same method (2.3 ns) [40] . Previously reported GQDs with attached IO (GQD-IOs) did not possess PL properties as they synthesized GQDs first and then attached IO [15] . Coating of IO onto the GQDs quenched the fluorescence of GQDs, which is similar to the quenching behavior of gold nanoparticles bonded to semiconductor QDs [80] . It was theorized that a QD would have its fluorescence quenched by a non-radiative energy dissipation process from the bonded nanoparticles, and not explicitly through a decrease in the radiative (PL) properties of the QD itself [80, 81] . In our process the GO-IO was synthesized first and then reduced to MGQDs; the reduction procedure broke the GO-IO into small QDs (Figure 2) , with the edges of the core-GQD within the MGQD now exposed. These edges have a zigzag structure that contain triple carbenes [82] which are linked to the electron orbital transition at 320 nm [25] , and so the PL properties of GQDs are preserved. The magnetic hysteresis loop of MGQDs ( Figure 6A ), determined with a SQUID, illustrate that they possess no residual magnetization and are superparamagnetic. The saturation magnetization of the MGQDs was 7.31 emu g -1 , comparable to other magnetic nanoparticles (4.62 emu g -1 ) [8] . As demonstrated in Figure 6A (Inset), the MGQDs can be drawn towards a magnet from a resting position. Figure 6B is the T2 relaxation time of
MGQDs from M.R.I., with the slope of the relaxation time determined as 4. 
Cell viability and imaging
MGQDs were found to have limited cytotoxicity up to a concentration of 50 µg ml white, and circular nodes: an appearance that was previously reported to indicate apoptosis [88] .
The cell viability of nanoparticles at higher concentrations can be improved upon by passivation with a coating of a biocompatible organic compound, with amine functionalized GQDs [23] and IO functionalized by pullulan [87] significantly improving the cell viability of the respective nanoparticles. Chitosan could also act as a passivation agent as previous work has shown that chitosan functionalized rGO was more stable in simulated body fluids than pristine GO [89] , and that chitosan functionalized graphene nanosheets are biocompatible and do promote the proliferation of cells [90] . to be cytotoxic after a long period of incubation ( Figure 7A ). Nevertheless, at 50 µg ml -1 it is still possible to image the nanoparticles. When surface-treated with a passivation agent,
MGQDs at a higher concentration such as 100 µg ml -1 may also be used without incurring toxicity to cells.
Drug delivery
The physical bonding of the anesthetic lidocaine hydrochloride (LH) ( Figure 9A , inset) onto
MGQDs to form MGQD-LH is mainly through π-π stacking between the aromatic rings of the MGQDs and LH [91] . Figure S2 shows the transposing of LH peaks onto MGQD in FT-IR (S2A) and Raman (S2B) spectra, showing that the LH is adsorbed to the surface of the MGQDs. A comparison of TGA curves of MGQD-LH with LH and MGQD ( Figure 9A) allows for the quantity of the drug in MGQD-LH to be estimated as 24 wt.%, giving an estimated loading ratio of LH:MGQD of 0.31:1. The drug release profile ( Figure 9B) determined that the release of LH from MGQD-LH into the PBS achieved ~100% (106.9 ± 13.1%) of the total drug available, or 5.09 (± 0.63) mg ml -1 , at 8 h, after which the test was terminated. To determine if the diffusion of LH from the MGQD follows Fickian law, Equation 2
was used [92] :
2 in which Q t is the amount of drug released at the time "t", Q T is the total amount of drug released during the experiment, K is the diffusion coefficient and n is the diffusion release exponent. It was found that the values of 0.56 µg s -1 and 0.55 for K and n best fit the experimental data presented in Figure 9B . This shows that the diffusion of the LH from the MGQD was not Fickian but anomalous [93] at pH = 7.4, similar to the diffusion of doxorubicin from GO [94] and rhodamine B from GO into a solution of pH = 4.5 [95] . These results indicate that a drug can be bonded to the surface of MGQDs and then be gradually released from the MGQDs into the body. It has been previously shown in the literature that similar nanoparticles like carbon QDs [28] , GO [96] and IO [6] can be extracted from the blood and collect in the spleen/bladder to be excreted from the body through urine. There is a possibility of using the MGQDs for cancer photothermal therapy, where the MGQDs absorb NIR light and convert it to heat that can be used to kill cancer cells locally [97] . To assess their potential for this application, suspensions of MGQDs in distilled water, together with GQD suspensions and distilled water control sample, were irradiated with a 2, shows that the MGQDs can be used as an effective photothermal ablation agent at a low concentration that was determined to have low cytotoxicity (Figure 7 ). The differences in suspension concentration, irradiation time, and irradiation power make direct comparisons between previously reported photothermal therapy agents difficult. But, generally MGQDs compare well to other nanoparticles that are structurally and elementally similar, in particular GO-poly(ethylene glycol) (PEG) [13] , rGO-PEG [13] , GO-IO [9] , and IO [14] . MQGDs also compare well to other photothermal agents such as carbon nanotubes [98] and gold nanoparticles [99] .
Photothermal properties
The photothermal therapy results suggest that the MGQDs could be potentially used for the ablation of tumours, where the presence of MGQDs within the tumour will raise the temperature and kill tumour cells locally [97] . MGQDs and GQDs were incubated for 4 h with HeLa cells for in vitro photothermal ablation studies ( Figure 10C ). Under 2.5 W cm attributed to reactive oxide species damage [100] . This difference may be due also to the rate of uptake of the MGQDs into the differing cells [100] ; for example, a previous report [101] shows the differing rates of uptake for uncoated IO into mouse macrophage and human breast cancer cells. Coating the IO with a biocompatible polymer such as PEG can lower the reactive oxide species effect on cells and affect the rate of uptake into cells [101] Previously, QDs such as CuS [102, 103] were used as photothermal ablation agents under irradiation with a 808 nm laser, with the QDs reducing the viability of HeLa cells [102] and of U87 glioblastoma cells [103] . When irradiated for 5 min with a 12 W cm -2 NIR laser, around ~65% of the tumour tissue in mice treated with CuS QDs showed signs of necrosis [103] . rGO-IO nanosheets achieved the full ablation of 4T1 tumours in mice that were treated with a 5 min exposure of 0.5 W cm -2 near-infrared laser irradiation [12] . In comparison to these results, our MGQDs are not as efficient as photothermal ablation agents under the laser irradiation conditions that we use, but they do offer bimodal imaging, with intrinsic M.R.I and fluorescent imaging capability. Also by increasing the laser power density (but still within the safe-use range), the photothermal ablation effect of the MGQDs may be improved.
Biostability
The stability of the MGQDs in biological fluids, including water, PBS and FCS, was assessed and the results are shown in Figure 11 . It can be seen that pristine MGQDs partially aggregate in distilled water and PBS (pH = 7.4) within 2 h, with larger particles falling to the bottom of the container, but the remaining particles remained stable in suspension as the quantity of aggregates did not increase with time up to 24 h. The IO on the surface of MGQD is hydrophobic [104] and aggregates in water and in PBS. MGQDs in FCS aggregated significantly within 2 h, presumably due to the crosslinking of MGQDs by hydrogen bonding of the proteins in the FCS with the remaining -COOH groups on MGQD edges [105] . The coating of LH onto the MGQD surface has reduced this crosslinking effect and greatly improved the biostability of the MGQD over 10 days ( Figure 11E ), with minimal further aggregation of the MGQD-LH after the initial 2 h. In solution, LH maintains a positive ionic charge [106] , and in FCS the LH coating prevents the MGQDs from aggregating through electrostatic repulsion. Coating the MGQDs with another ionic biopolymer, such as chitosan, may also improve the stability of the MGQDs, similar to the improvement afforded to chitosan-coated rGO [89] , as well as decreasing the cytotoxicity of the MGQDs [90] . 
Conclusions
The synthesis of MGQDs through the hydrothermal reduction of a water suspension of GO-IO nanoparticles was shown. The MGQDs were found to be around 45 nm in diameter and NIR irradiation, generated a higher temperature than GQDs or distilled water due to the presence of iron oxide which is a more effective NIR absorber, and could achieve more significant temperature increases at a low concentration and laser power. This higher NIR absorption allowed for the MGQDs to reduce the cell viability of cancer cells during in vitro laser ablation experiments by a greater amount than was possible with GQDs. Ionic drug coated MGQDs were shown to have a better stability in FCS than uncoated MGQDs, which showed the coated MGQDs were relatively stable in FCS over the test period (10 days).
These results demonstrate that the MGQDs have a low cytotoxicity and they retained the photoluminescent properties of GQDs which, in conjunction with the superparamagnetic properties from IO nanoparticles, would allow for fluorescent and M.R.I. dual-modality imaging in biomedical applications without the need to use an additional fluorescent dye.
Meanwhile, the MGQDs could be used as a targeted drug carrier via the physical bonding of a therapeutic to the MGQDs and the subsequent release of the therapeutic at the desired site by external magnetic stimulation, and as an effective potential agent for cancer photothermal therapy.
